Author page: Ella Ye

AFCR SUPPORTS various types of cancer and stages of research including basic, translational and clinical. As we celebrate this remarkable 20-year milestone, we honor the dedication of scientists, donors, and partners who have made these achievements possible. The future holds even greater promise as…

The Asian Fund for Cancer Research (AFCR) is committed to supporting groundbreaking cancer research and promoting accurate, science-based health information. In light of recent public discussions and a fact-check article published by the Taiwan FactCheck Center, we wish to clarify AFCR’s position…

This year marks a monumental milestone—the 20th anniversary of the Asian Fund for Cancer Research (AFCR). For two decades, your unwavering support has fueled groundbreaking discoveries, advanced life-saving treatments, and brought hope to millions of individuals and families affected by cancer. Today, we…

A Breakthrough Approach to “Undruggable” Targets THE CHALLENGE: Undruggable Targets In Cancer Many cancer-driving proteins remain out of reach for current treatments. These include transcription factors, RNA-binding proteins, and other intracellular regulators that lack suitable binding sites for traditional drugs. Biologic therapies,…

Position Overview: The Director of Marketing and Business Development at the Asian Fund for Cancer Research (AFCR) is responsible for driving the foundation’s growth in Hong Kong and the Asia-Pacific region by developing and executing comprehensive marketing strategies, managing strategic partnerships, and…

We are proud to recognize this year’s outstanding early-career Chinese cancer researchers for their remarkable contributions to advancing cancer research and drug development. Since 2010, the Asian Fund for Cancer Research and the US Chinese Anti-Cancer Association have jointly presented the USCACA-AFCR…

NOTABLE RESEARCH HIGHLIGHTS AFCR-supported scientists have made remarkable advances in the fight against cancer. Here are some notable research highlights in 2024 supported by your generous donations. First-in Class Molecular Glue Degraders Dr. Lily Zou’s research is at the forefront of developing a novel…

The 2024 Give to Cure Cancer Year-End Appeal is now underway. This is a chance to make this year’s campaign the most successful ever. We are proud to report... With support from loyal donors, excellent progress has been made in these AFCR-funded projects in…